Shanghai Pioneer Holding Ltd (HKG:1345)

Hong Kong · Delayed Price · Currency is HKD

2.290

-0.010 (-0.43%)

Jun 18, 2026, 3:46 PM HKT

4.09% (1Y)

Market Cap	2.65B +6.0%
Revenue (ttm)	1.43B -16.2%
Net Income	127.29M -24.6%
EPS	0.11 -23.7%
Shares Out	1.16B
PE Ratio	20.74
Forward PE	n/a
Dividend	0.12 (5.42%)
Ex-Dividend Date	Jun 3, 2026

Volume	92,000
Open	2.270
Previous Close	2.300
Day's Range	2.130 - 2.290
52-Week Range	1.590 - 2.400
Beta	-0.17
Analysts	Strong Buy
Price Target	3.39 (+48.04%)
Earnings Date	Aug 28, 2026

About Shanghai Pioneer Holding

Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, and imported in-licensed prescr... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

Founded 1996

Employees 364

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1345

Full Company Profile

Financial Performance

In 2025, Shanghai Pioneer Holding's revenue was 1.28 billion, a decrease of -16.17% compared to the previous year's 1.53 billion. Earnings were 114.38 million, a decrease of -24.56%.

Financial numbers in CNY Financial Statements